Brain Tumors
Getting treatment for brain and spinal tumors at City of Hope puts you at the center of the most innovative and clinical trials for brain cancer in the world, providing you access to promising treatments and cancer biology. Our Brain Tumor Program has several exciting experimental therapies, including:
- Genetically fortified immune system cells (CAR T cells), proven effective at treating glioblastoma in a groundbreaking study published in the New England Journal of Medicine.
- Neural stem cells delivering chemotherapy to advanced and treatment-resistant brain cancer
- Nanoparticles delivering cancer-killing therapies directly at tumor sites
For more information on our clinical trials or to refer a patient for enrollment with a newly developed or recurrent brain tumor, please email neurosurgerymail@coh.org.
“In the past, we never treated patients who had cancer that spread to the brain because we considered it terminal. But now that we’ve succeeded with drugs, partly invented at City of Hope, people with advanced cancer are living longer and longer.”
Rahul Jandial, M.D., Ph.D., Neurosurgeon and Scientist
Brain tumors are rare — fewer than 1% of the population is diagnosed with a malignant (cancerous) brain tumor during their lifetime. In addition, cancers that begin in the brain — primary brain tumors — are uncommon, while those that travel to brain tissue from other organs — called metastatic tumors — are more frequently diagnosed.
Brain tumors are highly complex, requiring an expert and deeply experienced team that can accurately diagnose your tumor type — so that you get the best and most effective treatment.
City of Hope’s approach to treating brain cancer starts with a coordinated, multidisciplinary care team whose primary goal is finding a treatment plan that extends your life.
City of Hope is a hub of innovation and progress when it comes to treating brain tumors.
Being diagnosed with brain cancer is a challenging and life-altering event. In addition to leading-edge care, City of Hope provides all patients with counseling, physical therapy and nutritional support.
Patient Stories
When you get brain tumor treatment at City of Hope, you are partnering with a world-class team of experts spanning multiple disciplines who see and treat challenging and complex brain tumors daily. And you have access to transformative surgical methods and technology, groundbreaking research studies, and highly focused radiation therapy. We treat all tumor types, including:
- Malignant (cancerous) tumors
- Benign (noncancerous) tumors, including pituitary gland disorders
- Tumors that have spread or developed resistance to treatment
- Complex spinal tumors
Promising New Brain Tumor Therapies
City of Hope's focus on basic research keeps us on the cusp of significant discoveries. For example, we are the only cancer center in the country injecting cancer-killing immune cells directly into the brain to treat patients with advanced brain tumors — to boost your immune system's natural cancer-fighting abilities. And we were the first research institution in the world to use neural stem cells in patients with glioblastoma.
Our commitment to providing exceptional care includes:
- Advanced immunotherapy and gene therapy clinical trials including using modified T cells to fight brain tumors
- Revolutionary neural stem cell therapy that delivers chemotherapy directly to tumors
- Promising research into immunotherapeutic approaches to killing brain cancer cells using nanoparticles
- Neurosurgeons who expertly perform minimally invasive procedures — including endoscopic and image-guided surgery — to maximize tumor tissue removal while preserving the quality of life
- A comprehensive pituitary tumor clinic
- Noninvasive, alternating electric field therapy that disrupts tumor cell division
- A brain tumor board, that regularly meets to discuss patient treatment plans
- Palliative procedures designed to improve quality of life
Seamless, Coordinated Cancer Care
City of Hope's team of neurosurgeons, neuro-oncologists, researchers, nurses, radiation oncologists and genetic counselors work together closely at every stage to provide seamless, coordinated care. We balance that approach with personalized medicine — not just when it comes to your cancer, but the kind that makes you feel supported throughout your treatment. Our commitment to personalized care means preserving your quality of life is at the heart of your treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Jana Portnow, M.D., is a medical oncologist and co-director of the Brain Tumor Program at City of Hope. She is dedicated to improving the treatment of the most aggressive and difficult brain cancers.
Behnam Badie, M.D., is a renowned neurosurgeon and expert in the field of surgical neuro-oncology, nanotechnology and T cell research.
Behnam Badie, M.D., is a renowned neurosurgeon and expert in the field of surgical neuro-oncology, nanotechnology and T cell research.
A prolific researcher and talented surgeon, Mike Y. Chen, M.D., Ph.D., has been on City of Hope's neurosurgery team since 2007. He specializes in complex operations for the removal of brain and spine tumors.
Lisa Feldman, M.D., Ph.D., is a neurosurgeon and assistant professor in the Department of Surgery at City of Hope.
City of Hope's neurosurgeon and scientist, Rahul Jandial, M.D., Ph.D., specializes in brain, spine and spinal cord cancers.
Michelle Afkhami, M.D., is a hematopathologist and molecular pathologist in the Department of Pathology at City of Hope.
Bihong (Beth) Chen, M.D., Ph.D., is a radiologist and researcher with a focus in neuroimaging, neuroradiology and body interventional radiology.
Massimo D'Apuzzo, M.D., is a neuropathologist and anatomic pathologist focusing on brain tumors.
Savita Dandapani, M.D., Ph.D., is a radiation oncologist at City of Hope who specializes in improving treatment outcomes and reducing side effects for cancer patients undergoing radiation therapy.
Neal Prakash, M.D., Ph.D., is a clinical professor of the Division of Neurology and director of neuro-optical imaging.
Eric H. Radany, M.D., Ph.D., has over 25 years of experience as a radiation oncologist and a well-earned reputation as an acknowledged expert in the field.
Julie Ann Ressler, M.D., is a clinical professor in the department of diagnostic radiology.
Leo David Wang, M.D., Ph.D., is a pediatric hematologist-oncologist and associate professor in the departments of Immuno-Oncology and Pediatrics.